Thursday, 16 July 2026
New AI Office launched, Pharmacy Guild under fire, Racist leaflet targets GPs
- 01
New Office of AI Established in Australia
Prime Minister Anthony Albanese announced the creation of a new Office of AI within the Department of the Prime Minister and Cabinet, aimed at coordinating a whole-of-government approach to artificial intelligence. Professor Enrico Coiera, founder of the Australian Alliance for AI in Healthcare, welcomed this development as a significant leadership signal for AI, although he noted the absence of specific references to healthcare in the announcement. The Office will oversee the establishment of national standards and a regulatory framework for large AI data centres. Coiera emphasised the need for tailored AI solutions that reflect Australia's healthcare system and population needs, particularly for Indigenous communities.
- 02
Pharmacy Guild Faces Scrutiny Over Misleading References
The Pharmacy Guild of Australia has been accused of using misleading references in a press release, following a critique from the RACGP. This incident comes amid a broader controversy after the Grattan Institute published a critical report on the pharmacy sector. The RACGP found that several references in the guild's rebuttal to a report on pharmacist-led prescribing were either incorrect or fabricated. The guild's spokesperson dismissed the RACGP's concerns as 'petty point scoring', while highlighting ongoing issues with patient access to GPs.
- 03
Racist Leaflet Targets Internationally Trained GPs in NSW
A racist leaflet promoting a 'remigration' rally has been distributed in Kurri Kurri, NSW, prompting concerns for the safety of internationally trained GPs. Hunter MP Dan Repacholi condemned the leaflet, linking it to a rise in aggressive behaviour towards overseas-trained doctors. The Australian Medical Association (NSW) emphasised the need for protective measures, noting that over 50% of doctors in rural areas are international medical graduates. The incident highlights the vulnerability of GPs in private practice, where they often lack security measures.
- 04
Avant survey reveals GPs burdened by referral delays
The Avant survey indicates that nearly half of GPs manage complex patient care while patients await specialist appointments, highlighting significant barriers in referral pathways. Long wait times, particularly in rural areas, contribute to increased GP workloads, with 48% of GPs often handling complex conditions themselves. The survey found that one third of patients wait three months or more for specialist care, with many prioritising shorter wait times. The findings underscore the need for systemic improvements in referral processes, as GPs navigate the challenges of both public and private referral pathways.
- 05
Registered nurses to gain PBS prescribing rights from October
From October 1, registered nurses (RNs) with special qualifications will be able to prescribe Pharmaceutical Benefits Scheme (PBS) medicines, following new legislation passed on July 2. This change allows designated RN prescribers to issue prescriptions for certain medications, which can be subsidised under the PBS, reducing out-of-pocket costs for patients. The reform aims to improve access to medications, particularly for those in aged care, rural areas, and those managing chronic conditions. However, the specific PBS medicines that RNs can prescribe are yet to be determined, and state laws regarding controlled substances will need updates.
- 06
CVS Caremark settles FTC insulin pricing allegations
CVS Health’s Caremark has settled with the Federal Trade Commission (FTC) over allegations of preferring more expensive insulin to increase rebates. The settlement mandates Caremark to prioritise lower-cost drugs and pass savings from drugmakers to clients. It also includes provisions to enhance transparency and prevent discrimination against independent pharmacies. The FTC estimates the settlement could save consumers up to $8.5 billion over the next decade, reflecting significant implications for drug pricing practices in the U.S.
via BioPharma Dive · also covered by Healthcare Dive
MDDR is a news digest for medical professionals. It is not medical advice and should not be relied on for clinical decision-making.